| Literature DB >> 35300171 |
Hayley E Fitzgerald1, Danielle L Hoyt1, M Alexandra Kredlow2, Jasper A J Smits3, Norman B Schmidt4, Donald Edmondson5, Michael W Otto1.
Abstract
Anxiety sensitivity (AS) is a transdiagnostic risk factor and potential treatment target for prevention of associated psychopathology and negative health behaviors. We conducted a meta-analysis evaluating the efficacy of brief interventions in at-risk samples for reducing AS and associated clinical/behavioral outcomes (e.g., depression, alcohol use) across 28 studies (1,998 participants). AS targeted interventions, compared to control conditions, evidenced a significant moderate effect size for alleviating AS from pre- to post-treatment (d = 0.54) and approached a large effect size from pre-treatment to short-term follow-up (d = 0.78). The effect size for long-term follow-up did not reach significance (d = 0.29). For clinical/behavioral outcomes, AS interventions demonstrated significant small-to-moderate effect sizes for the three timepoints examined (d's = 0.20-0.41). Our findings help validate AS as a modifiable mechanistic target for prevention efforts.Entities:
Keywords: anxiety sensitivity; efficacy; intervention; meta-analysis; prevention
Year: 2021 PMID: 35300171 PMCID: PMC8923531 DOI: 10.1037/cps0000038
Source DB: PubMed Journal: Clin Psychol (New York) ISSN: 0969-5893